Team-based Care for Patients with Type 2 Diabetes
Target Audience
Learning Objectives
Upon completion of this educational activity,the participant should be able to:
- Describe the benefits and risks of currently approved insulin therapies for the management of T2DM;
- Incorporate insulin into the management of patients with T2DM who do not achieve glycemic control;
- Intensify insulin therapy for patients with T2DM who do not achieve glycemic goals with initial insulin therapy;
- Summarize the current evidence-based practice guidelines for the management of T2DM;
- Develop strategies to overcome patient-related adherence barriers to the use of insulin in patients with T2DM.
COURSE FACULTY
Professor of Medicine
Director, Kovler Diabetes Center
The University of Chicago Pritzker School of Medicine
Chicago, IL
Assistant Professor, Section of General Internal Medicine
Associate Director, Center for Translational and Policy Research of Chronic Diseases
The University of Chicago Pritzker School of Medicine
Chicago, IL
Certified Diabetes Educator, Nutrition Specialist, Program Coordinator
Kovler Diabetes Center
The University of Chicago Pritzker School of Medicine
Chicago, IL
Disclosure Declarations
As a provider accredited by the ACCME, The University of Chicago Pritzker School of Medicine asks everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. This includes any entity producing, marketing, re-selling, or distributing health care goods or services consumed by or used on patients. The ACCME defines “relevant financial relationships” as financial relationships in any amount occurring within the past 12 months, including financial relationships of a spouse or life partner that could create a conflict of interest. Mechanisms are in place to identify and resolve any potential conflict of interest prior to the start of the activity.
Additionally, The University of Chicago Pritzker School of Medicine requires authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Chicago Pritzker School of Medicine and MCM Education in collaboration with RealCME. The University of Chicago Pritzker School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
The University of Chicago Pritzker School of Medicine designates this enduring material for a maximum of 1 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Click here to view the activity or if you are logged in click on the "Complete Activity" button!